NeillSMLewisFMNon-infective cutaneous conditions of the vulva. In: NeillSMLewisFM (eds). Ridley’s ‘The Vulva’, London: Wiley-Blackwell, 2009, pp. 115–123.
3.
NeillSMLewisFMTatnallFM. British Association of Dermatologists’ guidelines for the management of lichen sclerosus 2010. Br J Dermatol2010; 163: 672–682.
4.
OyamaNChanINeillSM. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet2003; 362: 118–123.
5.
Meyrick-ThomasRHRidleyCMMcGibbonDH. Lichen sclerosus and autoimmunity – a study of 350 women. Br J Dermatol1988; 118: 41–46.
6.
WallaceHJ. Lichen sclerosus et atrophicus. Trans St John’s Hosp Dermatol Soc1971; 57: 9–30.
7.
RegauerSReichO. Early vulvar lichen sclerosus: a histological challenge. Histopathology2005; 47: 340–347.
HenggeURKrauseWHofmannH. Multi-centre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol2006; 155: 1021–1028.
10.
NissiRRisteliJNiemimaaM. Pimecrolimus cream 1% in the treatment of lichen sclerosus. Gynecol Obstet Invest2006; 63: 151–154.
11.
EdeyKBissonDKennedyC. Topical tacrolimus in the management of lichen sclerosus. Br J Obstet Gynaecol2006; 113: 1482–1482.
12.
FischerGBradfordJ. Topical immunosuppressants, genital lichen sclerosus and the risk of squamous cell carcinoma. J Reprod Med2007; 52: 329–331.
13.
BousemaMTRomppanenUGeigerJM. Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo controlled study. J Am Acad Dermatol1994; 30: 225–231.
AbramovYElchalalUAbramovD. Surgical treatment of vulvar lichen sclerosus: a review. Obstet Gynecol Surv1996; 51: 193–199.
16.
CooperSMDeanDAllenJ. Erosive lichen planus of the vulva: weak circulating basement membrane zone antibodies are present. Clin Exp Dermatol2005; 30: 551–556.
17.
LewisFMShahMHarringtonCI. Vulval involvement in lichen planus: a study of 37 women. Br J Dermatol1996; 135: 89–91.
18.
GenadryRProvostTT. Severe vulvar scarring in patients with erosive lichen planus. J Reprod Med2006; 51: 67–72.
19.
CooperSMWojnarwowskaF. Influence of treatment of erosive lichen planus of the vulva on its prognosis. Arch Dermatol2006; 142: 362–364.
ReboraAParodiAMarialdoG. Basiliximab is effective for erosive lichen planus. Arch Dermatol2002; 138: 1100–1111.
22.
Lynch PJ, Moyal-Barracco M, Scurry J, et al. ISSVD terminology and classification of vulvar dermatological disorders: an approach to clinical diagnosis. In: Presented at the XXI world congress of the ISSVD, Paris, France, 3–8 September 2011.
23.
NardelliADegreefHGoossensA. Contact allergic reactions of the vulva: a 14 year review. Dermatitis2004; 15: 131–136.
24.
HaverhoekEReidCGordonL. Prospective study of patch testing in patients with vulval pruritis. Australas J Dermatol2008; 49: 80–85.
PetryKUKochelHBodeU. Human papillomavirus is associated with the frequent detection of warty and basaloid high-grade neoplasia of the vulva and cervical neoplasia among immunocompromised women. Gynecol Oncol1996; 60: 30–34.
32.
van SetersMvan BeurdenMde CraenAJ. Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol2005; 97: 645–651.
33.
JonesRWRowanDMStewartAW. Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women. Obstet Gynecol2005; 106: 1319–1326.
34.
AndreassonBMothIJensenSB. Sexual function and somatopsychic reactions in vulvectomy-operated women and their partners. Acta Obstet Gynecol Scand1986; 65: 7–10.
35.
PolterauerSCatharina DresslerAGrimmC. Accuracy of preoperative vulva biopsy and the outcome of surgery in vulvar intraepithelial neoplasia 2 and 3. Int J Gynecol Pathol2009; 28: 559–562.
36.
de BieRPvan de NieuwenhofHPBekkersRL. Patients with usual vulvar intraepithelial neoplasia-related vulvar cancer have an increased risk of cervical abnormalities. Br J Cancer2009; 101: 27–31.
37.
PepasLKaushikSBryantA. Medical interventions for high grade vulval intraepithelial neoplasia. Cochrane Database Syst Rev2011; 4: Art. No. CD007924–Art. No. CD007924.
38.
KaushikSPepasLNordinA. Surgical interventions for high grade vulval intraepithelial neoplasia. Cochrane Database Syst Rev2011; 1: Art. No. CD007928–Art. No. CD007928.
39.
HillemannsPWangXStaehleS. Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy. Gynecol Oncol2006; 100: 271–275.
40.
van SetersMvan BeurdenMKateFJ. Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med2008; 358: 1465–1473.
41.
MathiesenOBuusSKCramersM. Topical imiquimod can reverse vulvar intraepithelial neoplasia: a randomised, double-blinded study. Gynecol Oncol2007; 107: 219–222.
42.
von GruenigenVEGibbonsHEGibbinsK. Surgical treatments for vulvar and vaginal dysplasia: a randomized controlled trial. Obstet Gynecol2007; 109: 942–947.
43.
SillmanFHSedlisA. 5-FU/chemosurgery in the treatment of vulvar intraepithelial neoplasia. J Gynecol Surg1988; 4: 171–185.
44.
Moyal-BarraccoMLynchPJ. 2003 ISSVD terminology and classification of vulvodynia: a historical perspective. J Reprod Med2004; 49: 772–777.
45.
FarmerMATalorAMBaileyAL. Repeated vulvovaginal fungal infections cause persistent pain in a mouse model of vulvodynia. Sci Trans Med2011; 3: 101ra92–101ra92.
46.
MandalDNunnsDByrneM. Guidelines for the management of Vulvodynia. Br J Dermatol2010; 162: 1180–1185.
47.
SpoelstraSKDijkstraJRvan DrielMF. Long-term results of an individualized, multifaceted, and multidisciplinary therapeutic approach to provoked vestibulodynia. J Sex Med2011; 8: 489–496.
48.
Gentilcore-SaulnierEMcLeanLGoldfingerC. Pelvic floor muscle assessment outcomes in women with and without provoked vestibulodynia and the impact of a physical therapy program. J Sex Med2010; 7(2 Pt 2): 1003–1022.
49.
MurinaFBiancoVRadiciG. Transcutaneous electrical nerve stimulation to treat vestibulodynia: a randomised controlled trial. BJOG2008; 115: 1165–1170.
50.
MurinaFBernorioRPalmiottoR. The use of amielle vaginal trainers as adjuvant in the treatment of vestibulodynia: an observational multicentric study. Medscape J Med2008; 10: 23–23.
51.
DesrochersGBergeronSKhalifeS. Provoked vestibulodynia: psychological predictors of topical and cognitive-behavioral treatment outcome. Behav Res Ther2010; 48: 106–115.
52.
TommolaPUnkila-KallioLPaavonenJ. Long-term follow up of posterior vestibulectomy for treating vulvar vestibulitis. Acta Obstet Gynecol Scand2011; 90: 1225–1231.
53.
EvaLJNarainSOrakwueCO. Long-term follow up of posterior vestibulectomy for treating vulvar vestibulitis. J Reprod Med2008; 53: 435–440.
54.
PetersKGirdlerBCarricoD. Painful bladder syndrome/interstitial cystitis and vulvodynia: a clinical correlation. Int Urogynecol J2008; 19: 665–669.
55.
ReedBDCaronAMGorenfloDW. Treatment of vulvodynia with tricyclic antidepressants: efficacy and associated factors. J Low Genit Tract Dis2006; 10: 245–251.
56.
BrownCSWanJBachmannG. Self-management, amitriptyline, and amitriptyline plus triamcinolone in the management of vulvodynia. J Women's Health2009; 18: 163–169.
57.
HarrisGHorowitzBBorgidaA. Evaluation of gabapentin in the treatment of generalized vulvodynia, unprovoked. Evaluation of gabapentin in the treatment of generalized vulvodynia, unprovoked. J Reprod Med2007; 52: 103–106.
58.
JeromeL. Pregabalin-induced remission in a 62-year-old woman with a 20-year history of vulvodynia. Pain Res Manag2007; 12: 212–214.
59.
MashebRMKernsRDLozanoC. A randomized clinical trial for women with vulvodynia: cognitive-behavioral therapy vs supportive psychotherapy. Pain2009; 141: 31–40.
60.
PowellJWojnarowskaF. Acupuncture for vulvodynia. J R Soc Med1999; 92: 579–581.